US Nuclear Corp (OTC: UCLE) has reported a 72% reduction in loss from operations for the first quarter of 2026 compared to the same period in 2025, according to its recently filed quarterly report. The company reduced its operating loss by over $375,000, signaling progress in its turnaround efforts even as it works through delayed financial filings.
The company filed its US Nuclear Form 10Q_March 31, 2026 and expects to file its second-quarter report within the next three to four weeks. Trading of the company's stock is expected to resume after the release of its third-quarter results, projected for the first week of December. The delays stem from issues that pushed the 2025 annual report to June, which then impacted subsequent quarterly deadlines. "We lost some key people once we closed the LA operation, which made retrieving certain financial data from the closed operation more difficult, and we also chose to replace some people at Overhoff, but things are finally falling into place," said Michael Hastings, CFO of US Nuclear. The company has since engaged a new auditor and is implementing recommendations to make reporting faster and more efficient.
Operationally, US Nuclear has taken several steps that management believes will make 2027 a record year. In June, the company hired a General Manager/COO who is streamlining logistics, clearing backlogs, and accelerating product and service delivery. The company's backlog has grown to $1.2 million and is expected to reach $2.9 million by year-end. Additionally, US Nuclear is interviewing outsourced CPA firms to ensure timely and accurate financial reporting, with onboarding expected imminently.
The company is also working to re-launch its TA/Optron product line, which had been built in Los Angeles. Four college interns, under the GM's direction, are conducting a full marketing and product analysis to support a January 2027 relaunch, with hopes of adding $600,000 in revenues that year. Furthermore, US Nuclear has started discussions with other companies regarding potential joint ventures, an acquisition, or a reverse merger to go public. Management projects sales and profits to increase 20-30% in 2027, with sales doubling by 2028, or significantly higher if a transaction is completed in 2027.
These developments matter because they indicate that US Nuclear is addressing both its financial reporting challenges and its operational efficiency, which could restore investor confidence and unlock growth. The substantial reduction in operating loss demonstrates that cost-cutting and restructuring efforts are yielding results. The anticipated filing of the second and third quarters, along with the resumption of trading, will provide shareholders with greater transparency and liquidity. If the company achieves its backlog and revenue targets, it could mark a turning point after a period of delays and losses. However, risks remain, including the successful implementation of new financial reporting processes and the execution of product relaunches and strategic discussions. Investors can review the US Nuclear Form 10K_December 31, 2025 for a complete list of risks. The original release is available on www.newmediawire.com.
